# Gilead Sciences vs Pfizer: stocks compared

URL: https://funkfolio.com/compare/gild-vs-pfe

> Gilead Sciences ($211.2B) and Pfizer ($162.3B, P/E 40.7) compared: size, valuation, margins, debt, cash and price change.

---

## Gilead Sciences vs Pfizer

Gilead Sciences (GILD), health care, and Pfizer (PFE), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Gilead Sciences is worth $211.2B on the stock market and Pfizer $162.3B: Gilead Sciences is valued at 30% more. Over the past year Gilead Sciences's share price has moved +31.8% and Pfizer's +13.4%.

### Key facts

- **Gilead Sciences market value:** $211.2B
- **Pfizer market value:** $162.3B
- **Pfizer P/E:** 40.7
- **Gilead Sciences revenue:** $29.4B FY to 2025-12-31
- **Pfizer revenue:** $62.6B FY to 2025-12-31
- **Superinvestors holding both:** 1

Market values as of 18 Nov 2026, 02:52 UTC.

Gilead Sciences vs Pfizer: every measure side by side

| Measure | Gilead Sciences | Pfizer |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $211.2B higher | $162.3B lower |
| Revenue | $29.4B lower | $62.6B higher |
| Earnings | $8.5B higher | $7.8B lower |
| Employees | 17,000 lower | 75,000 higher |
| Total assets | $59B lower | $208.2B higher |
| Valuation |  |  |
| P/E | — | 40.7 |
| P/S | 7.2 higher | 2.6 lower |
| P/B | 16.2 higher | 1.8 lower |
| Dividend yield | 1.94% lower | 7.45% higher |
| Profitability |  |  |
| Operating margin | 34.0% | — |
| Balance sheet |  |  |
| Net assets | $22.7B lower | $86.5B higher |
| Total liabilities | $36.4B lower | $121.4B higher |
| Total debt | $24.9B lower | $64.8B higher |
| Cash on hand | $7.6B higher | $1.1B lower |
| Price change |  |  |
| Today | +1.60% higher | -1.35% lower |
| 1 year | +31.8% higher | +13.4% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Gilead Sciences 137.2, Pfizer 113.5.

- Gilead Sciences (GILD)
- Pfizer (PFE)

Gilead Sciences and Pfizer share prices over one year, rebased to 100: Gilead Sciences ends at 137.2, Pfizer at 113.5.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | GILD | PFE |
| --- | --- | --- |
| Nov 28, 2025 | 101.4 | 102.6 |
| Dec 31, 2025 | 98.9 | 99.3 |
| Jan 30, 2026 | 114.4 | 105.4 |
| Feb 27, 2026 | 120.0 | 110.2 |
| Mar 31, 2026 | 112.3 | 112.0 |
| Apr 30, 2026 | 105.4 | 106.5 |
| May 29, 2026 | 108.3 | 104.4 |
| Jun 30, 2026 | 101.8 | 96.0 |
| Jul 31, 2026 | 104.9 | 99.7 |
| Aug 31, 2026 | 117.9 | 113.5 |
| Sep 30, 2026 | 120.1 | 113.7 |
| Oct 30, 2026 | 137.5 | 121.7 |
| Nov 17, 2026 | 137.2 | 113.5 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (1)

- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.7% / 1.0%

#### Gilead Sciences only (9)

- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.7%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.9%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.4%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.3%
- [Fred DiSanto](https://funkfolio.com/gurus/fred-disanto) 0.3%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.3%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%

#### Pfizer only (10)

- [Thomas Kahn](https://funkfolio.com/gurus/thomas-kahn) 1.9%
- [Mark Boyar](https://funkfolio.com/gurus/mark-boyar) 1.6%
- [Prem Watsa](https://funkfolio.com/gurus/prem-watsa) 1.5%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.5%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.9%
- [Richard Pzena](https://funkfolio.com/gurus/richard-pzena) 0.5%
- [Bruce Berkowitz](https://funkfolio.com/gurus/bruce-berkowitz) 0.4%
- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 0.1%
- [Murray Stahl](https://funkfolio.com/gurus/murray-stahl) &lt;0.1%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Gilead Sciences / Pfizer). [Who owns GILD](https://funkfolio.com/stock/GILD/superinvestors) · [Who owns PFE](https://funkfolio.com/stock/PFE/superinvestors)

### More on Gilead Sciences

- [Gilead Sciences (GILD) stock page](https://funkfolio.com/stock/GILD)
- [Gilead Sciences market cap](https://funkfolio.com/stock/GILD/market-cap)
- [Gilead Sciences revenue](https://funkfolio.com/stock/GILD/revenue)
- [Gilead Sciences P/E ratio](https://funkfolio.com/stock/GILD/pe-ratio)
- [Gilead Sciences operating margin](https://funkfolio.com/stock/GILD/operating-margin)
- [Gilead Sciences total debt](https://funkfolio.com/stock/GILD/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Pfizer

- [Pfizer (PFE) stock page](https://funkfolio.com/stock/PFE)
- [Pfizer market cap](https://funkfolio.com/stock/PFE/market-cap)
- [Pfizer revenue](https://funkfolio.com/stock/PFE/revenue)
- [Pfizer P/E ratio](https://funkfolio.com/stock/PFE/pe-ratio)
- [Pfizer operating margin](https://funkfolio.com/stock/PFE/operating-margin)
- [Pfizer total debt](https://funkfolio.com/stock/PFE/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Gilead Sciences against its closest peers

- [Gilead Sciences vs Amgen](https://funkfolio.com/compare/amgn-vs-gild)
- [Gilead Sciences vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-gild)
- [Gilead Sciences vs Thermo Fisher Scientific](https://funkfolio.com/compare/gild-vs-tmo)
- [Gilead Sciences vs Novo Nordisk](https://funkfolio.com/compare/gild-vs-nvo)

#### Pfizer against its closest peers

- [Pfizer vs Danaher](https://funkfolio.com/compare/dhr-vs-pfe)
- [Pfizer vs Intuitive Surgical](https://funkfolio.com/compare/isrg-vs-pfe)
- [Pfizer vs Novo Nordisk](https://funkfolio.com/compare/nvo-vs-pfe)
- [Pfizer vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-pfe)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Gilead Sciences or Pfizer?**

By market value, Gilead Sciences is the larger: $211.2B against $162.3B for Pfizer. By revenue in its latest fiscal year, Pfizer is the larger: $62.6B against $29.4B for Gilead Sciences.

**Which has the higher dividend yield?**

Pfizer: 7.45%, against 1.94% for Gilead Sciences. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Pfizer: $64.8B, against $24.9B for Gilead Sciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Gilead Sciences and Pfizer?**

In their latest 13F filings, Josef Lakonishok holds both.

### Cite this page

Funkfolio, “Gilead Sciences vs Pfizer”, data as of 18 November 2026. https://funkfolio.com/compare/gild-vs-pfe

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
